GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HeiLongJiang ZBD Pharmaceutical Co Ltd (SHSE:603567) » Definitions » 5-Year Yield-on-Cost %

HeiLongJiang ZBD Pharmaceutical Co (SHSE:603567) 5-Year Yield-on-Cost % : 1.82 (As of May. 06, 2025)


View and export this data going back to 2015. Start your Free Trial

What is HeiLongJiang ZBD Pharmaceutical Co 5-Year Yield-on-Cost %?

HeiLongJiang ZBD Pharmaceutical Co's yield on cost for the quarter that ended in Mar. 2025 was 1.82.


The historical rank and industry rank for HeiLongJiang ZBD Pharmaceutical Co's 5-Year Yield-on-Cost % or its related term are showing as below:

SHSE:603567' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.17   Med: 1.32   Max: 2.11
Current: 1.82


During the past 13 years, HeiLongJiang ZBD Pharmaceutical Co's highest Yield on Cost was 2.11. The lowest was 0.17. And the median was 1.32.


SHSE:603567's 5-Year Yield-on-Cost % is ranked worse than
56.61% of 514 companies
in the Drug Manufacturers industry
Industry Median: 2.22 vs SHSE:603567: 1.82

Competitive Comparison of HeiLongJiang ZBD Pharmaceutical Co's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, HeiLongJiang ZBD Pharmaceutical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeiLongJiang ZBD Pharmaceutical Co's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HeiLongJiang ZBD Pharmaceutical Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where HeiLongJiang ZBD Pharmaceutical Co's 5-Year Yield-on-Cost % falls into.


;
;

HeiLongJiang ZBD Pharmaceutical Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of HeiLongJiang ZBD Pharmaceutical Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

HeiLongJiang ZBD Pharmaceutical Co  (SHSE:603567) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


HeiLongJiang ZBD Pharmaceutical Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of HeiLongJiang ZBD Pharmaceutical Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


HeiLongJiang ZBD Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 72, Hongxing Street, Hulin Town, Heilongjiang Province, Hulin, CHN, 158400
HeiLongJiang ZBD Pharmaceutical Co Ltd operates as a pharmaceutical manufacturer. The business scope of the company includes wholesale, retail, traditional Chinese medicine decoction pieces, Chinese medicine formula granules, Chinese herbal medicine trade, medical equipment, sanitary materials, and inspection and testing.
Executives
Li Tian Zhu senior management
Zhang Zhong Fang Director
Wang Lei senior management
Yan Jiu Jiang Directors, senior managers
Li Xiu Zhen senior management
Li Xue Dong Supervisors

HeiLongJiang ZBD Pharmaceutical Co Headlines

No Headlines